Ad
related to: regulus therapeutics
Search results
Regulus Therapeutics (RGLS): An Attractive Valuation or a Potential Value Trap?
GuruFocus.com via Yahoo Finance· 9 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
Regulus Therapeutics Inc's Uncertain Future: Understanding the Barriers to Outperformance
GuruFocus.com via Yahoo Finance· 9 months agoLong-established in the Biotechnology industry, Regulus Therapeutics Inc (NASDAQ:RGLS) has enjoyed a...
Regulus (RGLS) Up on Top-Line Data from Kidney Disease Study
Zacks via Yahoo Finance· 2 years agoRegulus Therapeutics (RGLS) reports positive top-line data from a phase I single-dose ascending...
Regulus Shares Surge After Early-Stage RGLS8429 Data In Rare Kidney Disease
Benzinga via Yahoo Finance· 2 years agoBiopharmaceutical company Regulus Therapeutics Inc (NASDAQ: RGLS) shares jumped after topline safety...
Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements
GuruFocus.com via Yahoo Finance· 2 months agoNet Loss: Reported a net loss of $8.1 million, or $0.40 per share, wider than the estimated loss per share of $0.21. Research and Development Expenses: Increased to $5.8 million for Q4 and $21.2 ...
Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) elected to terminate its second amended and restated collaboration and...
Regulus (RGLS) Surges on Enrollment Completion for RGLS8429
Zacks via Yahoo Finance· 1 year agoRegulus’ RGLS shares were up almost 35% on Apr 13, after it announced the completion of patient...
Regulus: Q4 Earnings Snapshot
AP Finance via Yahoo Finance· 1 year agoSAN DIEGO (AP) — SAN DIEGO (AP) — Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $6.8 million in its fourth quarter. On a per-share basis, the San Diego-based company said it ...
13 Best Biotech Penny Stocks To Buy Now
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we will be taking a look at the 13 best biotech penny stocks to buy now. To skip our detailed analysis of these stocks, you can go...
Amid RNA Setbacks, Start Up Bets On Sanofi's siRNA Platform
Benzinga via Yahoo Finance· 2 years agoLow profile startup Rona Therapeutics Inc has obtained exclusive rights worldwide to Sanofi SA's...
